User: Guest  Login
Document type:
Meeting Abstract
Author(s):
Petrylak, D. P.; Perez-Gracia, J. L.; Lacombe, L.; Bastos, D. A.; Mahammedi, H.; Kwan, E. M.; Zschaeitz, S.; Armstrong, A. J.; Pachynski, R. K.; Goh, J. C.; Burotto, M.; Gravis, G.; McCune, S. L.; Vazquez Limon, J. C.; Retz, M.; Saad, F.; Amin, N. P.; Li, J.; Unsal-Kacmaz, K.; Fizazi, K.
Title:
CheckMate 9KD cohort A2 final analysis: Nivolumab (NIVO) plus rucaparib for chemotherapy (CT)-naive metastatic castration-resistant prostate cancer (mCRPC)
Journal title abbreviation:
Ann Oncol
Year:
2021
Journal volume:
32 Suppl 5
Pages contribution:
S629-S630
Fulltext / DOI:
doi:10.1016/j.annonc.2021.08.1092
Print-ISSN:
0923-7534
TUM Institution:
Urologische Klinik und Poliklinik
 BibTeX